DK3201323T3 - Modificering af bakteriofag - Google Patents
Modificering af bakteriofag Download PDFInfo
- Publication number
- DK3201323T3 DK3201323T3 DK15775457.3T DK15775457T DK3201323T3 DK 3201323 T3 DK3201323 T3 DK 3201323T3 DK 15775457 T DK15775457 T DK 15775457T DK 3201323 T3 DK3201323 T3 DK 3201323T3
- Authority
- DK
- Denmark
- Prior art keywords
- bacteriophage
- modification
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10111—Myoviridae
- C12N2795/10121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10111—Myoviridae
- C12N2795/10141—Use of virus, viral particle or viral elements as a vector
- C12N2795/10144—Chimeric viral vector comprising heterologous viral elements for production of another viral vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1417810.7A GB201417810D0 (en) | 2014-10-08 | 2014-10-08 | Modifying bacteriophage |
| PCT/EP2015/073296 WO2016055586A1 (en) | 2014-10-08 | 2015-10-08 | Modifying bacteriophage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3201323T3 true DK3201323T3 (da) | 2020-02-03 |
Family
ID=51947056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15775457.3T DK3201323T3 (da) | 2014-10-08 | 2015-10-08 | Modificering af bakteriofag |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10953052B2 (da) |
| EP (1) | EP3201323B1 (da) |
| JP (1) | JP6748074B2 (da) |
| AU (1) | AU2015329959B2 (da) |
| CA (1) | CA2963690A1 (da) |
| DK (1) | DK3201323T3 (da) |
| ES (1) | ES2768773T3 (da) |
| GB (1) | GB201417810D0 (da) |
| HR (1) | HRP20200171T1 (da) |
| HU (1) | HUE047552T2 (da) |
| LT (1) | LT3201323T (da) |
| PL (1) | PL3201323T3 (da) |
| PT (1) | PT3201323T (da) |
| SI (1) | SI3201323T1 (da) |
| WO (1) | WO2016055586A1 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201417810D0 (en) | 2014-10-08 | 2014-11-19 | Phico Therapeutics Ltd | Modifying bacteriophage |
| GB2544957B (en) * | 2015-07-15 | 2020-05-27 | Phico Therapeutics Ltd | Modifying bacteriophage |
| ES2867029T3 (es) * | 2016-04-08 | 2021-10-20 | Phico Therapeutics Ltd | Bacteriófago modificado |
| EP3440204A1 (en) | 2016-04-08 | 2019-02-13 | Phico Therapeutics Ltd | Modifying bacteriophage |
| CN109661464A (zh) | 2016-06-30 | 2019-04-19 | 技术创新动力基金（以色列）有限合伙公司 | 具有扩展宿主范围的噬菌体变体、其制备方法及其在将核酸转导至感兴趣的宿主中的用途 |
| CA3219077A1 (en) * | 2021-05-12 | 2022-11-17 | Eligo Bioscience | Production of lytic phages |
| WO2023187041A1 (en) | 2022-03-30 | 2023-10-05 | Biological Research Centre | Metagenomic libraries |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2417188A1 (en) | 2000-07-25 | 2002-01-31 | Carl R. Merril | Bacteriophage having multiple host range |
| GB0028130D0 (en) | 2000-11-17 | 2001-01-03 | Phico Therapeutics Ltd | Polypeptide and uses thereof |
| WO2003076583A2 (en) | 2002-03-06 | 2003-09-18 | Musc Foundation For Research Development | Genetically engineered phage and the use of genetically engineered phage to deliver nucleic acid to bacteria |
| GB0314469D0 (en) * | 2003-06-20 | 2003-07-23 | Phico Therapeutics Ltd | Antimicrobial compositions and uses thereof |
| US7244612B2 (en) * | 2004-10-07 | 2007-07-17 | University Of Wyoming | Template reporter bacteriophage platform and multiple bacterial detection assays based thereon |
| GB0715416D0 (en) | 2007-08-07 | 2007-09-19 | Phico Therapeutics Ltd | Modified bacteriophage |
| WO2009055697A1 (en) * | 2007-10-24 | 2009-04-30 | The Texas A & M University System | Chimeric phage tail proteins and uses thereof |
| GB201417810D0 (en) | 2014-10-08 | 2014-11-19 | Phico Therapeutics Ltd | Modifying bacteriophage |
-
2014
- 2014-10-08 GB GBGB1417810.7A patent/GB201417810D0/en not_active Ceased
-
2015
- 2015-10-08 JP JP2017518842A patent/JP6748074B2/ja active Active
- 2015-10-08 DK DK15775457.3T patent/DK3201323T3/da active
- 2015-10-08 PT PT157754573T patent/PT3201323T/pt unknown
- 2015-10-08 CA CA2963690A patent/CA2963690A1/en active Pending
- 2015-10-08 WO PCT/EP2015/073296 patent/WO2016055586A1/en active Application Filing
- 2015-10-08 US US15/517,732 patent/US10953052B2/en active Active
- 2015-10-08 LT LTEP15775457.3T patent/LT3201323T/lt unknown
- 2015-10-08 AU AU2015329959A patent/AU2015329959B2/en active Active
- 2015-10-08 HU HUE15775457A patent/HUE047552T2/hu unknown
- 2015-10-08 EP EP15775457.3A patent/EP3201323B1/en active Active
- 2015-10-08 SI SI201531088T patent/SI3201323T1/sl unknown
- 2015-10-08 PL PL15775457T patent/PL3201323T3/pl unknown
- 2015-10-08 ES ES15775457T patent/ES2768773T3/es active Active
-
2020
- 2020-02-03 HR HRP20200171TT patent/HRP20200171T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2015329959B2 (en) | 2021-11-04 |
| US10953052B2 (en) | 2021-03-23 |
| ES2768773T3 (es) | 2020-06-23 |
| AU2015329959A1 (en) | 2017-04-20 |
| US20170304379A1 (en) | 2017-10-26 |
| PT3201323T (pt) | 2020-02-14 |
| HUE047552T2 (hu) | 2020-04-28 |
| AU2015329959A9 (en) | 2019-08-01 |
| HRP20200171T1 (hr) | 2020-05-15 |
| EP3201323A1 (en) | 2017-08-09 |
| WO2016055586A1 (en) | 2016-04-14 |
| JP6748074B2 (ja) | 2020-08-26 |
| GB201417810D0 (en) | 2014-11-19 |
| WO2016055586A9 (en) | 2019-02-07 |
| EP3201323B1 (en) | 2019-11-06 |
| JP2017529868A (ja) | 2017-10-12 |
| PL3201323T3 (pl) | 2020-05-18 |
| SI3201323T1 (sl) | 2020-07-31 |
| LT3201323T (lt) | 2020-04-10 |
| CA2963690A1 (en) | 2016-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3137169T3 (da) | Hæmmere af lysin-specifik demethylase-1 | |
| DK3851537T5 (da) | Behandling af hyperbilirubinæmi | |
| DK3192902T3 (da) | Fremgangsmåde til fremstilling af graphenholdige viscosefibre | |
| DK3102576T3 (da) | Dihydropyrrolopyridininhibitorer af ror-gamma | |
| DK3180331T3 (da) | Polymorfer af selinexor | |
| DK3178817T3 (da) | Amorf form af tetracyklisk forbindelse | |
| DK3160956T3 (da) | Inhibitorer af lysin-specifik demethylase-1 | |
| DK3164380T3 (da) | Hæmmere af lysinspecifik demethylase-1 | |
| DK3117030T3 (da) | Diagnosticering af sepsis | |
| DK3514109T3 (da) | Hydropyrolyse af biomasseholdige råmaterialer | |
| DK3110442T3 (da) | Modificerede meningokok-fhbp-polypeptider | |
| DK3307267T3 (da) | Behandling af multipel sklerose | |
| DK3283210T3 (da) | Fremgangsmåde | |
| DK3132009T3 (da) | Fremgangsmåde | |
| DK3201323T3 (da) | Modificering af bakteriofag | |
| DK3368044T3 (da) | Behandling af hepatisk steatose-relateret oligo-ovulation | |
| DK3511000T3 (da) | Krystallinsk form x2 af grapiprant | |
| DK3204352T3 (da) | Hæmmere af lysin-gingipain | |
| DK3137449T3 (da) | Fremgangsmåder til fremstilling af substituerede cycloseriner | |
| DK3125942T3 (da) | Forstøvning af immunoglobulin | |
| DK3297619T3 (da) | Terapeutiske anvendelser af L-4-chlorkynurenin | |
| DK3418273T3 (da) | Derivater af flavagliner | |
| DK2897382T3 (da) | Forbedring af binaural kilde | |
| DK3430004T3 (da) | Faststofformer af nilotinibsalte | |
| DK3200783T3 (da) | Behandling af erytromelalgi |